Dr. Justin Sanchez explains to host Dr. Larry Kaskel the latest research regarding neuroprosthetics. These prosthetics directly interface and decode brain communications. The greatest development arises in utilizing smart prosthetics called "brain chips" that learn with the patient overtime, and someday may be used routinely to help paralyzed patients control prosthetic limbs with their thoughts. Dr. Sanchez outlines the underlying mechanisms of these devices and the current research within humans. Tune in to hear how these brain-machine interfaces are being used to control prosthetics, and the potential applications to cure diseases such as epilepsy, addiction and Alzheimer's.
A Pacemaker for the Brain? Developments in Neuroprosthetics
Restart
Resume
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
Dr. Justin Sanchez explains to host Dr. Larry Kaskel the latest research regarding neuroprosthetics. These prosthetics directly interface and decode brain communications. The greatest development arises in utilizing smart prosthetics called "brain chips" that learn with the patient overtime, and someday may be used routinely to help paralyzed patients control prosthetic limbs with their thoughts. Dr. Sanchez outlines the underlying mechanisms of these devices and the current research within humans. Tune in to hear how these brain-machine interfaces are being used to control prosthetics, and the potential applications to cure diseases such as epilepsy, addiction and Alzheimer's.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
MinuteCE®
I'm Getting the Hang of This! I Have Two Patients: One At 'Indeterminate Risk' and One At 'High Risk' for Clinically Significant Fibrosis
1.00 credits
<p>I'm Getting the Hang of This! I Have Two Patients: One At 'Indeterminate Risk' and One At 'High Risk' for Clinically Significant Fibrosis</p>
MinuteCE®
M3: Managing the Cardiometabolic Risk in MASH
1.00 credits
<p><span data-contrast="auto" xml:lang="EN-US">M3: Managing the Cardiometabolic Risk in MASH</span><span data-ccp-props='{"201341983":0,"335559739":160,"335559740":259}'> </span></p>
Perspectives with the AMA
Implementing the AMA MAPTM Hypertension Program: A Clinician’s Experience
<p>Implementing the AMA MAP™ Hypertension Program: A Clinician's Experience</p>
MinuteCE®
Application of guidelines-recommended broad molecular profiling to patients with NSCLC
1.00 credits
<p>Application of guidelines-recommended broad molecular profiling to patients with NSCLC</p>
MinuteCE®
Clinical evidence driving guideline recommendations for frontline immunotherapy-based combination regimens in metastatic urothelial cancer
1.25 credits
<p>Clinical evidence driving guideline recommendations for frontline immunotherapy-based combination regimens in metastatic urothelial cancer</p>
MinuteCE®
Guideline Considerations for Immunotherapy in Primary Advanced or Recurrent Endometrial Cancer
1.00 credits
<p>Guideline Considerations for Immunotherapy in Primary Advanced or Recurrent Endometrial Cancer</p>
CME/CE
Impact of Barostim on Heart Failure Hospitalization
<p>Impact of Barostim on Heart Failure Hospitalization</p>
NeuroFrontiers
Navigating Myasthenia Gravis in Adolescents and Young Adults
<p>Navigating Myasthenia Gravis in Adolescents and Young Adults</p>
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?